Selecting the Right Tumors for Genomic Testing David M. Euhus Breast Oncology 12 November 2018 Pages: 313 - 314
Management of Regional Lymph Nodes in Patients with Merkel Cell Carcinoma Following a Positive Sentinel Node Biopsy: Less May be More, But is Either Enough? George HrubyAlexander GuminskiJohn F. Thompson Endocrine Tumors 27 November 2018 Pages: 315 - 317
Biomarkers of Bad Biology: Curse or a Blessing? Sudeep BanerjeeJason K. Sicklick Colorectal Cancer 11 December 2018 Pages: 318 - 320
A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study Xin TangXiaojuan ZhouYouling Gong Health Services Research and Global Oncology 24 October 2018 Pages: 321 - 328
Multifocal/Multicentric Ipsilateral Invasive Breast Carcinomas with Similar Histology: Is Multigene Testing of All Individual Foci Necessary? Anne GrabenstetterEdi BrogiHannah Y. Wen Breast Oncology 08 October 2018 Pages: 329 - 335
Does Lymph Node Status Prior to Neoadjuvant Chemotherapy Influence the Number of Sentinel Nodes Removed? Jennifer L. BakerShirin MuhsenMary L. Gemignani Breast Oncology 30 November 2018 Pages: 336 - 342
The Role of the Neo-Bioscore Staging System in Guiding the Optimal Strategies for Regional Nodal Irradiation Following Neoadjuvant Treatment in Breast Cancer Patients with cN1 and ypN0–1 Lu CaoCheng XuJia-Yi Chen Breast Oncology 05 December 2018 Pages: 343 - 355
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis Elvire Pons-TostivintYoulia KirovaFlorence Dalenc Breast Oncology 11 December 2018 Pages: 356 - 365
Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy Alison M. PeaseLuis A. RibaTed A. James Breast Oncology 12 December 2018 Pages: 366 - 371
Regional Recurrence Risk Following a Negative Sentinel Node Procedure Does Not Approximate the False-Negative Rate of the Sentinel Node Procedure in Breast Cancer Patients Not Receiving Radiotherapy or Systemic Treatment Marleen M. RoosJulia E. C. van SteenhovenThijs van Dalen Breast Oncology 01 November 2018 Pages: 372 - 378
Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both? Matthew C. PerezDaniel E. OliverJonathan S. Zager Melanoma 11 October 2018 Pages: 379 - 385
Completion Lymph Node Dissection or Radiation Therapy for Sentinel Node Metastasis in Merkel Cell Carcinoma Jay S. LeeAlison B. DurhamWilliam R. Burns Melanoma 17 December 2018 Pages: 386 - 394
Validation of a Nomogram for Non-sentinel Node Positivity in Melanoma Patients, and Its Clinical Implications: A Brazilian–Dutch Study Eduardo BertolliViola FrankeAlexander C. J. van Akkooi Melanoma 19 November 2018 Pages: 395 - 405
Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy Keigo YokoiHiroki HaradaKeishi Yamashita Translational Research and Biomarkers 11 October 2018 Pages: 406 - 414
The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells Takato YomodaTomoya SudoYoshito Akagi Translational Research and Biomarkers 19 December 2018 Pages: 415 - 424
Learning by Example: An International Perspective on Reflex-Testing for Lynch Syndrome Vanessa N. PalterNatalie A. BakerNancy N. Baxter Colorectal Cancer 01 October 2018 Pages: 425 - 436
Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes Robin DeteringWernard A. A. BorstlapDutch Snapshot Research Group Colorectal Cancer Open access 13 December 2018 Pages: 437 - 448
Feasibility of Endoscopic Resection in Early Gastric Cancer with Lymphovascular Invasion Jeung Hui PyoHyuk LeeJae J. Kim Gastrointestinal Oncology 18 December 2018 Pages: 449 - 455
The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set Song RyoMitsuro KandaYasuhiro Kodera Gastrointestinal Oncology 18 December 2018 Pages: 456 - 464
Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy Yoshiaki NakamuraTakeharu YamanakaKohei Shitara Gastrointestinal Oncology 19 November 2018 Pages: 465 - 472
Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Carlos Munoz-ZuluagaArmando SardiVadim Gushchin Gastrointestinal Oncology 06 December 2018 Pages: 473 - 481
Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience Yael FefermanDaniel SolomonDaniel M. Labow Gastrointestinal Oncology 11 December 2018 Pages: 482 - 489
Restrictive Intraoperative Fluid Therapy is Associated with Decreased Morbidity and Length of Stay Following Hyperthermic Intraperitoneal Chemoperfusion Ryan J. HendrixAneel DamleLaura A. Lambert Peritoneal Surface Malignancy 04 December 2018 Pages: 490 - 496
Surgeon Volume and Surgeon Age in Relation to Proficiency Gain Curves for Prognosis Following Surgery for Esophageal Cancer Eivind Gottlieb-VediHugh MackenzieJesper Lagergren Gastrointestinal Oncology Open access 15 October 2018 Pages: 497 - 505
Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma Po-Kuei HsuHui-Shan ChenShiao-Chi Wu Gastrointestinal Oncology 14 November 2018 Pages: 506 - 513
Specific Tumor Characteristics Predict Upstaging in Early-Stage Esophageal Cancer Kelly R. HaisleyChristopher M. HartJohn G. Hunter Thoracic Oncology 30 October 2018 Pages: 514 - 522
Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery Giuseppe VizzielliRaj NaikDavid Cibula Gynecologic Oncology 11 December 2018 Pages: 523 - 530
Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment Joachim ReibetanzBritta RinnChristian Jurowich Endocrine Tumors 15 November 2018 Pages: 531 - 538
Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism Shonan ShoEric J. KuoMasha J. Livhits Endocrine Tumors 07 November 2018 Pages: 539 - 546
Does p16+ Predict a Favorable Prognosis for Oropharyngeal Cancer? Risk Factors for Treatment Failure for Patients Who Underwent Surgery-Based Therapy Young Min ParkMin Seok KangSe-Heon Kim Head and Neck Oncology 01 October 2018 Pages: 547 - 554
A Multicenter Retrospective Study of Elective Neck Dissection for T1-2N0M0 Tongue Squamous Cell Carcinoma: Analysis Using Propensity Score-Matching Mitsunobu OtsuruYoshihide OtaAyumi Shintani Head and Neck Oncology Open access 04 December 2018 Pages: 555 - 563
Perioperative and Long-Term Outcomes of Laparoscopic Versus Open Lymphadenectomy for Biliary Tumors: A Propensity-Score-Based, Case-Matched Analysis Francesca RattiGuido FiorentiniLuca Aldrighetti Hepatobiliary Tumors 01 October 2018 Pages: 564 - 575
Hepatic Angiosarcoma: A Multi-institutional, International Experience with 44 Cases Gregory C. WilsonNuria LluisDavid A. Geller Hepatobiliary Tumors 19 November 2018 Pages: 576 - 582
Robotic Versus Open Minor Liver Resections of the Posterosuperior Segments: A Multinational, Propensity Score-Matched Study Carolijn L. NotaYanghee WooYuman Fong Hepatobiliary Tumors 17 October 2018 Pages: 583 - 590
ASO Author Reflections: The Role of Robotic Surgery in Liver Resection Carolijn L. NotaJeroen HagendoornYuman Fong ASO Author Reflections 11 December 2018 Pages: 591 - 592
Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis Masanori OshiGeorgios Antonios MargonisItaru Endo Hepatobiliary Tumors 27 November 2018 Pages: 593 - 603
National Failure of Surgical Staging for T1b Gallbladder Cancer Elaine VoSteven A. CurleyHop S. Tran Cao Hepatobiliary Tumors 29 November 2018 Pages: 604 - 610
Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma Thuy B. TranCecilia G. EthunGeorge A. Poultsides Hepatobiliary Tumors 11 December 2018 Pages: 611 - 618
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma Pat GulhatiLaura PrakashGauri R. Varadhachary Pancreatic Tumors 15 October 2018 Pages: 619 - 627
Increased SOX9 Expression in Premalignant and Malignant Pancreatic Neoplasms Jennifer L. GnerlichXianzhong DingGerard V. Aranha Pancreatic Tumors 24 October 2018 Pages: 628 - 634
Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma Wei JinHua-Xiang XuXian-Jun Yu Pancreatic Tumors 29 October 2018 Pages: 635 - 643
Significance of 18F-Fluorodeoxyglucose (FDG) Uptake in Response to Chemoradiotherapy for Pancreatic Cancer Hiroshi KuraharaKosei MaemuraShoji Natsugoe Pancreatic Tumors 06 December 2018 Pages: 644 - 651
Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma Eve SimoneauClaire GoumardChing-Wei D. Tzeng Pancreatic Tumors 11 December 2018 Pages: 652 - 652
The Value of 99mTc-PSMA SPECT/CT-Guided Surgery for Identifying and Locating Lymph Node Metastasis in Prostate Cancer Patients Heng-chuan SuYao ZhuDing-Wei Ye Urologic Oncology 15 October 2018 Pages: 653 - 659
Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists Simon P. KimCary P. GrossNeal J. Meropol Urologic Oncology 11 October 2018 Pages: 660 - 668
Combination of the Preoperative Systemic Immune-Inflammation Index and Monocyte-Lymphocyte Ratio as a Novel Prognostic Factor in Patients with Upper-Tract Urothelial Carcinoma Hau-Chern JanWen-Horng YangChien-Hui Ou Urologic Oncology 29 October 2018 Pages: 669 - 684
Important Therapeutic Considerations in T1b Penile Cancer: Prognostic Significance and Adherence to Treatment Guidelines Yao ZhuWei-Jie GuDing-Wei Ye Urologic Oncology 18 December 2018 Pages: 685 - 691
ASO Author Reflections: T1b Penile Cancer: An Alarm to Improve Treatment Yao ZhuPhilippe E. SpiessDing-Wei Ye ASO Author Reflections 17 December 2018 Pages: 692 - 693
Completion Thyroidectomy: Revisited a Quarter of a Century Later Benzon M. DyVeljko StrajinaAshok R. Shaha Endocrine Tumors 07 December 2018 Pages: 694 - 696
Reply to “Differences in the Impact of Age on Mortality in Well-Differentiated Thyroid Cancer” Norman G. NicolsonTobias Carling Endocrine Tumors 12 December 2018 Pages: 697 - 697
